0001209191-20-010324.txt : 20200218 0001209191-20-010324.hdr.sgml : 20200218 20200218180310 ACCESSION NUMBER: 0001209191-20-010324 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200213 FILED AS OF DATE: 20200218 DATE AS OF CHANGE: 20200218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FARBER STEPHEN D CENTRAL INDEX KEY: 0001205449 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12111 FILM NUMBER: 20626741 MAIL ADDRESS: STREET 1: 680 SOUTH FOURTH STREET CITY: LOUISVILLE STATE: KY ZIP: 40202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDNAX, INC. CENTRAL INDEX KEY: 0000893949 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 263667538 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 BUSINESS PHONE: 9543840175 MAIL ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 FORMER COMPANY: FORMER CONFORMED NAME: PEDIATRIX MEDICAL GROUP INC DATE OF NAME CHANGE: 19950801 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-13 0 0000893949 MEDNAX, INC. MD 0001205449 FARBER STEPHEN D 1301 CONCORD TERRACE SUNRISE FL 33323 0 1 0 0 Chief Financial Officer Common Stock 2020-02-13 4 A 0 88791 0.00 A 238742 D Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 22,198 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2020. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on March 1, 2021, March 1, 2022 and March 1, 2023, subject to the terms of the Plan. /s/ Dominic J. Andreano, Attorney-in-Fact 2020-02-18